Tiecheng Yang

Dr. Tiecheng Yang


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2025 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
QLQiujing Li
Qiujing Li
NSNa Shang
Na Shang
QGQian Gao
Qian Gao
SGShu-Bin Guo
Shu-Bin Guo
TYTiecheng Yang
Tiecheng Yang
Studies on the prevalence of sarcopenia and its relationship with other geriatric syndromes among older patients with sepsis in the emergency department (ED) are scarce. This study aimed to investigate the prevalence of sarcopenia among older patients with sepsis and explore its association with specific geriatric symptoms: frailty and malnutrition. This cross-sectional study was carried out in China from January to November 2022. Muscle mass, as indicated by the skeletal muscle index (SMI) was measured using abdominal plain computed tomography. Sarcopenia, frailty, and nutritional status were defined according to the Asian Working Group for Sarcopenia 2019 criteria, Clinical Frailty Scale (CFS) score, and Mini Nutritional Assessment-Short Form (MNA-SF) score. The correlations of the SMI with the CFS and MNA-SF scores were analyzed using nonparametric Spearman correlation analysis. Univariate and multivariable logistic regression analyses were performed to determine the associations of sarcopenia with frailty and malnutrition. A total of 602 patients (332 men; median age, 78 years; median body mass index, 23.1 kg/m2) were included. Sarcopenia, frailty, and malnutrition were present in 36.2%, 58.0%, and 34.6% of the patients, respectively. Of the 602 patients, 414 (68.8%) had at least one geriatric syndrome, 253 (42.0%) had at least two simultaneously. The SMI correlated negatively with the CFS score and positively with the MNA-SF score (all p < 0.001). The CFS (adjusted odds ratio [OR] = 1.384 per 1-point increase, p < 0.001) and MNA-SF (adjusted OR = 0.887 per 1-point increase, p = 0.002) scores were independently associated with sarcopenia. Frailty (adjusted OR = 3.816, p = 0.003), being at risk of malnutrition (adjusted OR = 2.466, p = 0.001), and being malnourished (adjusted OR = 2.477, p = 0.002) were independently associated with sarcopenia. Sarcopenia and coexisting geriatric syndromes were prevalent and interrelated among older patients with sepsis in EDs. Clinicians should assess older patients with sepsis for geriatric syndromes to provide them with more accurate interventions. This study was registered at www.chictr.org.cn (registration number: ChiCTR2300070377, date: 11–04-2023).

1 September 2024 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
SYSongsong Yu
Songsong Yu
TYTiecheng Yang
Tiecheng Yang
Pneumocystis jirovecii pneumonia is an opportunistic infection that affects HIV-infected and immunocompromised persons and rarely affects immunocompetent patients. However, after the advent of the COVID-19 pandemic, some COVID-19 patients without immunocompromise or HIV were infected with P. jirovecii. Clinical manifestations were atypical, easily misdiagnosed, and rapidly progressive, and the prognosis was poor.

1 January 2025 in Pulmonary Medicine
Verified
Journal Article
Open access
SYSongsong Yu
Songsong Yu
TYTiecheng Yang
Tiecheng Yang
Aim: The aim of the study is to evaluate the distribution and drug resistance of infectious pathogens in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods: This is a retrospective study of AECOPD patients who underwent pathogen evaluation and drug susceptibility tests. Results: A total of 199 hospitalized AECOPD patients were analyzed. Among them, 77.9% had monoinfection, and 22.1% had multiple infections. Two hundred and eighty‐eight strains were isolated, with 61.1% gram‐negative, 3.8% gram‐positive, and 35.0% fungi, while 58 strains were colonized. Common bacteria included Haemophilus parainfluenzae , Acinetobacter baumannii , and Pseudomonas aeruginosa . Staphylococcus aureus and Enterococcus faecalis were the main gram‐positive cocci, and Pseudohyphae were the main fungi. Fifty gram‐negative strains showed drug resistance (19 colonized strains), with high resistance to ceftriaxone in A. baumannii , P. aeruginosa , Klebsiella pneumoniae , and Escherichia coli . Methicillin‐resistant S. aureus was resistant to penicillin but sensitive to other antibiotics. Conclusion: The study highlights the distribution of pathogens and the prevalence of drug‐resistant strains among AECOPD patients.

23 May 2025 in Medicine
Verified
Journal Article
Open access
BCBiyao Chen
Biyao Chen
ZCZheng Chen
Zheng Chen
QGQian Gao
Qian Gao
QLQiujing Li
Qiujing Li
TYTiecheng Yang
Tiecheng Yang
Levosimendan has demonstrated beneficial effects in the treatment of acute decompensated heart failure (ADHF). However, it is also associated with proarrhythmic effects owing to its influence on cardiac electrophysiology. We aimed to analyze the clinical features of atrial fibrillation (AF) after levosimendan treatment in patients with ADHF and to identify the predictors of AF after levosimendan treatment. The data of patients with ADHF treated with levosimendan were propensity score-matched and retrospectively analyzed. This study retrospectively collected patients admitted to the emergency department between 2021 and 2024 with a diagnosis of acute decompensated heart failure who received levosimendan therapy. Overall, 38 patients (16.8%) developed AF after levosimendan treatment. Levosimendan therapy was an independent predictor of AF (odds ratio 1.442, 95% confidence interval 1.005–2.067; P = .014). Patients who developed AF were older (P < .001) and more likely to have comorbid left atrial enlargement (P < .001) and previous AF/atrial flutter (P = .004). Patients with AF after levosimendan treatment had a longer median in-hospital stay than those without AF. Age (P = .005), left atrial enlargement (P = .032), and history of atrial flutter/AF (P = .002) were significant predictors of AF after levosimendan treatment. The area under the receiver operating characteristic curve values for age, left atrial enlargement, and history of atrial flutter/AF for predicting AF after treatment with levosimendan were 0.679 (P < .001), 0.687 (P < .001), and 0.603 (P = .012), respectively. Age, left atrial enlargement, and previous atrial flutter/AF were independent predictors of AF after levosimendan treatment. Levosimendan-associated AF increased the length of in-hospital stay, but had no effect on in-hospital mortality. Although this was a retrospective study, the study was registered as a clinical study, and the registration numbers will be uploaded later.